The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?

Roelofs, Kelsey A; O'Day, Roderick; Harby, Lamis Al; Arora, Amit K; Cohen, Victoria M L; Sagoo, Mandeep S; Damato, Bertil

Roelofs, Kelsey A; O'Day, Roderick; Harby, Lamis Al; Arora, Amit K; Cohen, Victoria M L; Sagoo, Mandeep S; Damato, Bertil.

Afiliação

Roelofs KA; Ocular Oncology Service, Moorfields Eye Hospital, London EC1V 2PD, UK.
O'Day R; Ocular Oncology Service, Moorfields Eye Hospital, London EC1V 2PD, UK.
Harby LA; Ocular Oncology Clinic, Royal Victorian Eye and Ear Hospital, Melbourne VIC 3002, Australia.
Arora AK; Ocular Oncology Service, Moorfields Eye Hospital, London EC1V 2PD, UK.
Cohen VML; Ocular Oncology Service, Moorfields Eye Hospital, London EC1V 2PD, UK.
Sagoo MS; NIHR Biomedical Research Centre for Ophthalmology, University College London Institute of Ophthalmology; London EC1V 9EL; UK.
Damato B; Ocular Oncology Service, Moorfields Eye Hospital, London EC1V 2PD, UK.

Cancers (Basel) ; 12(5)2020 May 21.

Article em En | MEDLINE | ID: mdl-32455720

Palavras-chave

choroidal melanoma; choroidal nevi; scoring system

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google